Progress in the use of statins in cancers of the digestive system

doi:10.3877/cma.j.issn.2095-7157.2019.03.007

Abstract

Abstract:

With the rapid development of the economy, the change of people's diet structure and environmental pollution, the incidence and mortality of cancer in the digestive system show an increasing trend. Surgery is the first choice in the early stage, and radiotherapy、chemotherapy、immunotherapy and targeted therapy can be adopted in the later stage. In recent years, several studies have shown that the use of statins in digestive cancer can reduce the mortality and cancer risk of cancer patients to some extent.This article mainly discusses that progress in the use of statins in cancers of the digestive system, which is expected to find new adjuvant drugs for the treatment of cancer.

Key words: Statins, Esophageal cancer, Gastric cancer, Liver cancer, Biliary tract cancer, Pancreatic cancer, Colorectal cancer

Zhen Yang, Jinpeng Hu, Min Niu, Yan Zhou, Ling Zhang, Xue Zhang, Feihu Bai. Progress in the use of statins in cancers of the digestive system[J]. Chinese Journal of Gastrointestinal Endoscopy(Electronic Edition), 2019, 06(03): 125-129.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhwcnjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-7157.2019.03.007

https://zhwcnjdzzz.cma-cmc.com.cn/EN/Y2019/V06/I03/125

References 38

[1]	邓俊丽，张蕊，唐洁，等. 他汀类药物抗肿瘤作用的研究进展[J]. 中国临床药理学与治疗学， 2017, 22(1): 92-99.
[2]	谢抒睿，徐本华．他汀类药物在直肠癌新辅助放化疗中的研究进展[J]．中华放射肿瘤学杂志，2019，28(5): 394-397.
[3]	Fitzmaurice C, Allen C, Barber RM，et al.Global，regional，and national cancer incidence，mortality，years of life lost，years lived with disability，and disability-adjusted life-years for 32 cancer groups，1990 to 2015: a systematic analysis for the global burden of disease study global burden[J]．JAMA Oncol，2017，3(4): 524-548.
[4]	Lagergren J, Smyth E, Cunningham D，et al. Oesophageal cancer [J]．Lancet，2017，390(10110): 2383-2396.
[5]	Coleman HG, Xie SH, Lagergren J. The-epidemiology-of-esophageal- adenocarcinoma[J]．Gastroenterology，2018，154(2): 390-405.
[6]	Abnet CC, Arnold M, Wei WQ. Epidemiology of esophageal squamous cell carcinoma[J]．Gastroenterology，2018，154(2): 360-373.
[7]	Spence AD, Busby J, Johnston BT，et al. Low-dose aspirin use does not increase survival in 2 independent population-based cohorts of patients with esophageal or gastric cancer[J]．Gastroenterology, 2018，154(4): 849-860.
[8]	Theresa Nguyen, Anam Khan, Yan Liu，et al. the Association Between Statin use After diagnosis and Mortality risk in Patients With Esophageal cancer：A retrospective cohort Study of united States Veterans[J] .Am J Gastroenterol，2018，113(9): 1310.
[9]	Nguyen DM, Richardson P, El-Serag HB.Medications(NSAIDs，statins，proton pump inhibitors)and the risk of esophageal adenocar-cinoma in patients with Barrett's esophagus[J]. Gastroenterology，2010，138(7): 2260-2266.
[10]	Olivia Lacroix, Alexandra Couttenier1, Evelien Vaes，et al. Statin use after diagnosis is associated with an increased survival in esophageal cancer patients: a Belgian population-based study[J]. Cancer Causes Control，2019，30(4): 385-393.
[11]	Tom Thomas, Yoon Loke, Ian LP，et al. Systematic Review and Meta-analysis: Use of Statins Is Associated with a Reduced Incidence of Esophageal Adenocarcinoma[J]．J Gastrointest Cancer，2018，49(4): 442-454.
[12]	Liang D, Liang S, Jin J，et al. Gastric cancer burden of last 40 years in North China(Hebei Province)：a population-based study[J]. Medicine(Baltimore)，2017，96(2): e5887.
[13]	Singh PP, Singh S．Statins are associated with reduced risk of gastric cancer: a systematic review and meta-analysis[J]．Ann Oncol，2013，24(7): 1721-1730.
[14]	Nielsen SF, Nordestgaard BG, Bojesen SE. Statin use and reduced cancer-related mortality[J]. N Engl J Med，2012，367(19): 1792-1802.
[15]	Andrew D. Spence, John Busby, Carmel M. Hughes，et al. Statin use and survival in patients with gastric cancer in two independent population-based cohorts[J]．Pharmacoepidemiology and Drug Safety，2019，28(4): 460-470.
[16]	Shi M, Zheng H, Nie B，et al. Statin use and risk of liver cancer: an update meta-analysis[J]．BMJ Open 2014，4: e005399.
[17]	Aaron P. Thrift, Yamini Natarajan, Yan Liu，et al. Statin Use After Diagnosis of Hepatocellular Carcinoma Is Associated With Decreased Mortality[J]. Clin Gastroenterol Hepatol ，2019，17(10): 2117-2125.
[18]	Katherine A. McGlynn, Katrina Hagberg，et al. Statin Use and Risk of Primary Liver Cancer in the Clinical Practice Research Datalink[J]. J Natl Cancer Inst，2015，107(4): djv009.
[19]	Wu Li-Li , Hsieh Mao-Chih, PhD，et al. Statins improve outcomes of nonsurgical curative treatments in hepatocellular carcinoma patients[J]. Medicine，2016，95(36): 1-11.
[20]	Konstantinos P, Konstantinos Stavropoulos, Michael Doumas，et al. The potential role of statins in treating liverdisease[J]．Exp Rev Gastroenterol Hepatol，2018，12(1): 1-9.
[21]	Singh S, Singh PP, Roberts LR，et al. Chemopreventive strategies in hepatocellular carcinoma[J]. Nat Rev Gastroenterol Hepatol，2014，11(1): 45-54.
[22]	Valle JW, lamarca a, goyal l，et al. new Horizons for precision medicine in biliary tract cancers[J]．Cancer Discov，2017，7(9): 943-962.
[23]	王葵，沈丰．肝内胆管癌的诊治进展[J]．肝胆外科杂志，2019，1(1): 1-6.
[24]	liu Z, alsaggaf r, Mcglynn Ka，et al. Statin use and reduced risk of biliary tract cancers in the UK Clinical Practice Research Data link [J]．Gut，2019，68(8): 1458-1464.
[25]	Antonopoulos AS, Margaritis M, Lee R， et al. Statins as anti- in？ammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials[J]. Curr Pharm Des，2012，18(11): 1519-1530.
[26]	Albert M A, Danielson E, Rifai N, Ridker PM. Effect of statin therapy on c-reactive protein levels: the pravastatin in ammation/crP evaluation (Prince): a randomized trial and cohort study[J]. JAMA，2001，286(1): 64-70.
[27]	Blechacz B, Komuta M, Roskams T，et al. Clinical diagnosis and staging of cholangiocarcinoma[J]．Nat Rev Gastroenterol Hepatol，2011, 8(9): 512-522.
[28]	Shin HR, Oh JK, Masuyer E，et al.Epidemiology of cholangiocarcinoma: an update focusing on risk factors[J]．Cancer Sci，2010，101(3): 579-585.
[29]	Peng Yc, lin cl, Hsu WY，et al. Statins are associated with a reduced risk of cholangiocarcinoma：a population-based case-control study[J]. Br J Clin Pharmacol，2015，80(4): 755-761.
[30]	Ferlay J, Soerjomataram I, Dikshit R，et al. Cancer incidence and mortality worldwide: sources，methods and major patterns in GLOBOCAN 2012[J] .Int J Cancer，2015，136(5): E359-E386.
[31]	Hee Seung Lee, Sang Hoon Lee, Hyun Jik Lee，et al. Statin Use and Its Impact on Survival in Pancreatic Cancer Patients[J]．Medicine，2016，95(19): 1-7.
[32]	Wu BU, Chang J, Jeon CY，et al. Impact of statin use on survival inpatients undergoing resection for early-stage pancreatic cancer[J]. Am J Gastroenterol，2015，110(8): 1233-1239.
[33]	E Jian-Yu, Judith M. Graber，Shou-En Lu，et al. Effect of Metformin and Statin Use on Survival in Pancreatic Cancer Patients: a Systematic Literature Review and Metaanalysis[J]．Curr Med Chem，2018，25(22): 2595-2607.
[34]	Zhang Yun, Liang Mingming, Sun Chenyu，et al. Statin Use and Risk of Pancreatic Cancer An Updated Meta-analysis of 26 Studies[J]. Pancreas，2019，48(2): 142-150.
[35]	Fitzmaurice c, allen c, Barber rM，et al. global，regional，and national cancer incidence，mortality，years of life lost，years lived with disability，and disability adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study[J]. JAMA Oncol, 2017，3(4): 524-548.
[36]	Cai H, Zhang G, Wang Z，et al. Relationship Between the Use of Statins and Patient Survival in Colorectal Cancer: A Systematic Review and Meta-Analysis[J]．PLoS ONE，2015，10(6): e0126944.
[37]	Hiroshi Yokomichi, Akiko Nagai, Makoto Hirata，et al. Statin use and all-cause and cancer mortality：BioBank Japan cohort[J]．J Epidemiol，2017，27(3): 84-91.
[38]	Małgorzata Dobrzycka, Piotr Spychalski, Andrzej J. achiński，et al. Statins and Colorectal Cancer - A Systematic Review[J]．Exp Clin Endocrinol Diabetes，2018，25(4): 1-8.
	cheung Ka-Shing, chen lijia, esther W chan，et al. Statins reduce the progression of non-advanced adenomas to colorectal cancer: a postcolonoscopy study in 187897 patients[J]. Gut ，2019，68(2): 1-7.

Please choose a citation manager

Content to export